The scope of CO-induced N(2) cleavage in a series of zirconocene and hafnocene complexes containing activated, side-on bound dinitrogen ligands has been studied. In each case, bridging oxamidide ligands, [N(2)C(2)O(2)](4-), were formed from N-N bond cleavage coupled to N-C and C-C bond assembly. For the zirconium examples, [(eta(5)-C(5)Me(4)H)(2)Zr](2)(mu(2),eta(2),eta(2)-N(2)) and [Me(2)Si(eta(5)-C(5)Me(4))(eta(5)-C(5)H(3)-3-(t)Bu)Zr](2)(mu(2),eta(2),eta(2)-N(2)), dinitrogen loss became competitive with N(2) carbonylation, and significant quantities of the zirconocene dicarbonyl accompanied oxamidide formation. In contrast, the hafnocene complex [(eta(5)-C(5)Me(4)H)(2)Hf](2)(mu(2),eta(2),eta(2)-N(2)) underwent clean carbonylative dinitrogen cleavage with no evidence of N(2) loss. CO-induced N(2) cleavage was also coupled to N-H bond formation by hydrogenation and C-H bond activation, as carbonylation of the zirconocene and hafnocene dinitrogen complexes in the presence of H(2) or phenylacetylene furnished isocyanato metallocene complexes with bridging imido (mu-NH) ligands. In the case of the ansa-hafnocene dinitrogen complex, replacing the dihydrogen atmosphere with various primary silanes yielded an isocyanato hafnocene mu-oxo hydride resulting from cleavage of N(2) and CO, the diatomics with the two strongest bonds in chemistry.
No takes yet. Share an insight, caveat, or question.
Knobloch et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: